From China to the Global Stage: Hengrui Showcases Innovative Research at ESMO Congress 2026, Exploring New Approaches to Oncology Treatment
Record 64 Research Presentations Highlight Hengrui’s Oncology R&D Strength and Growing International Reach SHANGHAI and MADRID, Oct. 28, 2026 /PRNewswire/ — The European Society for Medical Oncology (ESMO) Congress 2026 recently concluded

